Aeglea Biotherapeutics — Redefining the Possible. Human Enzyme Therapies for People with Rare Diseases · Slide 362023
Alkermes — Nemvaleukin Alfa: A Novel, Engineered Interleukin-2 (IL-2) Variant Immunotherapy · Slide 92022